Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Viale

Showing results (201-210 of 302) with videos related to

Pageof 31
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 28, 2013
A simple and reproducible prognostic index in luminal ER-positive breast cancersI Castellano, L Chiusa, A M Vandone, et al.
Breast Cancer Research and Treatment|April 21, 2015
Angiosarcoma and atypical vascular lesions of the breast: diagnostic and prognostic role of MYC gene amplification and protein expressionC Fraga-Guedes, S André, M G Mastropasqua, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 3, 2005
Metronomic low-dose oral cyclophosphamide and methotrexate plus or minus thalidomide in metastatic breast cancer: antitumor activity and biological effectsM Colleoni, L Orlando, G Sanna, et al.
European Journal of Cancer (Oxford, England : 1990)|June 20, 2013
High Ki67 predicts unfavourable outcomes in early breast cancer patients with a clinically clear axilla who do not receive axillary dissection or axillary radiotherapyS Zurrida, V Bagnardi, G Curigliano, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 21, 2015
Risk of subsequent in situ and invasive breast cancer in human epidermal growth factor receptor 2-positive ductal carcinoma in situG Curigliano, D Disalvatore, A Esposito, et al.
Cancer|February 1, 1997
p53 protein accumulation and p53 gene mutation in esophageal carcinoma. A molecular and immunohistochemical study with clinicopathologic correlationsG Coggi, S Bosari, M Roncalli, et al.
European Journal of Cancer (Oxford, England : 1990)|December 1, 1996
Quantification of angiogenesis in solid human tumours: an international consensus on the methodology and criteria of evaluationP B Vermeulen, G Gasparini, S B Fox, et al.
British Journal of Cancer|August 23, 2007
Antitumour and biological effects of letrozole and GnRH analogue as primary therapy in premenopausal women with ER and PgR positive locally advanced operable breast cancerR Torrisi, V Bagnardi, G Pruneri, et al.
International Journal of Cancer|January 9, 2001
Inhibition of matrix metalloproteinases by over-expression of tissue inhibitor of metalloproteinase-2 inhibits the growth of experimental hemangiomasV Vergani, A Garofalo, M R Bani, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 17, 2009
A risk score to predict disease-free survival in patients not achieving a pathological complete remission after preoperative chemotherapy for breast cancerM Colleoni, V Bagnardi, N Rotmensz, et al.
Pageof 31

Showing results (201-210 of 302) with videos related to

Sort By:
Pageof 31
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 28, 2013
A simple and reproducible prognostic index in luminal ER-positive breast cancersI Castellano, L Chiusa, A M Vandone, et al.
Breast Cancer Research and Treatment|April 21, 2015
Angiosarcoma and atypical vascular lesions of the breast: diagnostic and prognostic role of MYC gene amplification and protein expressionC Fraga-Guedes, S André, M G Mastropasqua, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 3, 2005
Metronomic low-dose oral cyclophosphamide and methotrexate plus or minus thalidomide in metastatic breast cancer: antitumor activity and biological effectsM Colleoni, L Orlando, G Sanna, et al.
European Journal of Cancer (Oxford, England : 1990)|June 20, 2013
High Ki67 predicts unfavourable outcomes in early breast cancer patients with a clinically clear axilla who do not receive axillary dissection or axillary radiotherapyS Zurrida, V Bagnardi, G Curigliano, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 21, 2015
Risk of subsequent in situ and invasive breast cancer in human epidermal growth factor receptor 2-positive ductal carcinoma in situG Curigliano, D Disalvatore, A Esposito, et al.
Cancer|February 1, 1997
p53 protein accumulation and p53 gene mutation in esophageal carcinoma. A molecular and immunohistochemical study with clinicopathologic correlationsG Coggi, S Bosari, M Roncalli, et al.
European Journal of Cancer (Oxford, England : 1990)|December 1, 1996
Quantification of angiogenesis in solid human tumours: an international consensus on the methodology and criteria of evaluationP B Vermeulen, G Gasparini, S B Fox, et al.
British Journal of Cancer|August 23, 2007
Antitumour and biological effects of letrozole and GnRH analogue as primary therapy in premenopausal women with ER and PgR positive locally advanced operable breast cancerR Torrisi, V Bagnardi, G Pruneri, et al.
International Journal of Cancer|January 9, 2001
Inhibition of matrix metalloproteinases by over-expression of tissue inhibitor of metalloproteinase-2 inhibits the growth of experimental hemangiomasV Vergani, A Garofalo, M R Bani, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 17, 2009
A risk score to predict disease-free survival in patients not achieving a pathological complete remission after preoperative chemotherapy for breast cancerM Colleoni, V Bagnardi, N Rotmensz, et al.
Pageof 31